Compare two ways to plan treatment for cervical cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study compares two staging methods—using surgery results versus imaging tests—to help doctors plan treatment for locally advanced cervical cancer. It may improve how accurately the cancer is mapped, which could affect treatment choices and outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can understand the study and sign the consent form voluntarily
- Your cervical cancer is one of these types: squamous cell, adenocarcinoma, or adenosquamous
- Your cancer stage is IB3, IIA2, or IIB to IVA (per FIGO 2018 staging)
- Your general health ability score is 0 to 1 (can do most daily activities)
- You’re expected to live more than 6 months
- If you can get pregnant: a test within 7 days is negative and you will use birth control during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a combination of chemotherapy and immunotherapy (pembrolizumab) before surgery works better than standard chemoradiation for locally advanced cervical cancer. It may help shrink tumors more effectively.
This trial tests a combination of pelvic chemoradiation (chemotherapy and radiation) with a special type of brachytherapy (internal radiation) that adjusts the dose during treatment for locally advanced cervical cancer. It aims to improve tumor control while keeping side effects manageable.
This trial tests a new combination of chemotherapy and immunotherapy before standard chemoradiation for locally advanced cervical cancer. The goal is to see if adding immunotherapy first helps shrink the tumor and improve treatment outcomes.
This trial tests two immunotherapy drugs (iparomlimab and tuvonralimab) combined with chemotherapy before surgery for locally advanced cervical cancer. It aims to shrink tumors and improve outcomes for patients who haven't had prior systemic treatment.
This trial studies whether removing lymph nodes during surgery helps people with stage IIICr cervical cancer. It looks at outcomes and may help guide better treatment for lymph node spread.
This trial looks at whether adding chemotherapy after standard chemoradiation helps people with locally advanced cervical cancer. You may be eligible if your MRI after treatment still shows leftover tumor areas and your health and blood tests are within required limits.
Hear when a new Locally Advanced Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.